Amaryl and Bleeding into the skin - a phase IV clinical study of FDA data

Summary:

Bleeding into the skin is reported as a side effect among people who take Amaryl (glimepiride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Coumadin, and have High blood pressure.

The phase IV clinical study analyzes which people have Bleeding into the skin when taking Amaryl. It is created by eHealthMe based on reports of 31,980 people who have side effects when taking Amaryl from the FDA, and is updated regularly.

What is Amaryl?

Amaryl has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 32,259 Amaryl users. Check the latest studies of Amaryl.

What is Bleeding into the skin?

Bleeding into the skin is found to be associated with 937 drugs and 1,911 conditions by eHealthMe. Check the latest studies of Bleeding into the skin.

On Jul, 31, 2026

31,980 people reported to have side effects when taking Amaryl.
Among them, 34 people (0.11%) have Bleeding into the skin.

Could Amaryl cause Bleeding into the skin?

Among these 34 people:

How long have people been on Amaryl when they have Bleeding into the skin? *

What is the gender of people who have Bleeding into the skin when taking Amaryl? *

female: 41.18 %
male: 58.82 %

What is the age of people who have Bleeding into the skin when taking Amaryl? *

What are other drugs people take besides Amaryl? *

What are other side effects people have besides Bleeding into the skin? *

Thrombocytopenia (decrease of platelets in blood): 22 people, 64.71%
Anaemia (lack of blood): 9 people, 26.47%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 8 people, 23.53%
Dyspnea (difficult or laboured breathing): 7 people, 20.59%
Diarrhea: 6 people, 17.65%
Fever: 6 people, 17.65%
Ascites (accumulation of fluid in the abdominal cavity): 6 people, 17.65%
Purpura (purplish discoloration of the skin): 5 people, 14.71%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 5 people, 14.71%
Nausea And Vomiting: 5 people, 14.71%

What are the existing conditions these people have? *

High Blood Pressure: 8 people, 23.53%
Renal Cell Carcinoma Stage Iii (cancer is found in the main blood vessels of the kidney or in the layer of fatty tissue around the kidney. cancer may be found in 1 or more nearby lymph nodes): 3 people, 8.82%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 8.82%
Multiple Myeloma (cancer of the plasma cells): 3 people, 8.82%
Renal Cell Carcinoma (a kidney cancer): 1 person, 2.94%
Renal Cancer Stage Iv (the tumour has spread to areas beyond gerota's fascia and extends into the adrenal gland on the same side of the body as the tumour, possibly to lymph nodes, but not to other parts of the body): 1 person, 2.94%
Pleural Disorder: 1 person, 2.94%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 2.94%
Lung Disorder (lung disease): 1 person, 2.94%
High Blood Cholesterol: 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Amaryl and have Bleeding into the skin?

- Check whether Bleeding into the skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amaryl:

Amaryl (32,259 reports)

Browse all side effects of Amaryl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bleeding into the skin:

Bleeding into the skin (937 drugs)

Browse all the conditions that are associated with Bleeding into the skin:

Bleeding into the skin (1,911 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glimepiride (the active ingredients of Amaryl) and Amaryl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.